|
Real-time Estimate
Cboe BZX
13:38:01 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 23.35 USD | -4.77% |
|
-7.73% | -2.31% |
| 09-22 | Arcus Biosciences, Inc. Announces New Data for Casdatifan as Treatment for Kidney Cancer Across Multiple Lines of Therapy | CI |
| 09-16 | TD Cowen Initiates Arcus Biosciences at Buy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Other Biotechnology & Medical Research | -4.93% | -7.73% | -2.31% | +54.68% | -26.05% | 3.12B |  | |  |
- Stock Market
- Stocks
- RCUS Stock
- Charts Arcus Biosciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
